Association between essential tremor and blood lead concentration

Environmental Health Perspectives

Volumn 111, Issue 14, 2003, Pages 1707-1711

  Louis, Elan D ^a,b,c,f   Jurewicz, Eva C ^a   Applegate, Lakeisha ^a   Factor Litvak, Pam ^d   Parides, Michael ^d   Andrews, Leslie ^d   Slavkovich, Vesna ^d   Graziano, Joseph K ^c,d   Carroll, Spencer ^e   Todd, Andrew ^e  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Neurological Institute ^*  (United States)

^d NONE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Epidemiology; Essential tremor; Etiology; Lead; Occupational exposure

Indexed keywords

LEAD;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHEMICAL REACTION KINETICS; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL TREMOR; ETHNOLOGY; FEMALE; FREQUENCY ANALYSIS; GENDER; HUMAN; INDUSTRIAL HYGIENE; LEAD BLOOD LEVEL; LEAD POISONING; LIFESPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 10744223466     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6404     Document Type: Article

References (58)

1. Booze RM, Mactutus CF, Annau Z, Tilson HA. 1983. Neonatal triethyl lead neurotoxicity in rat pups: initial behavioral observations and quantification. Neurobehav Toxicol Teratol 5:367-375.
2. Börjesson J, Gerhardsson L, Schütz A, Mattsson S, Skerfving S, Österberg K. 1997. In vivo measurements of lead in fingerbone in active and retired lead smelters. Int Arch Occup Environ Health 69:97-105.
3. Brandt J, Spencer M, Folstein M. 1988. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1:111-117.
4. Brody DJ, Pirkle JL, Kramer RA, Flegal KM, Matte TD, Gunter EW, et al. 1994. Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA 272:277-283.
5. Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. 1997. Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol 41:32-40.
6. Cheng Y, Willett WC, Schwartz J, Sparrow D, Weiss S, Hu H. 1998. Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol 147:1162-1174.
7. Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED. 2003. Rest tremor in essential tremor patients: prevalence, clinical correlates, and electrophysiological characteristics. Arch Neurol 60:405-410.
8. Coulehan JL, Hirsch W, Brillman J, Sanandria J, Welty TK, Colaiaco P, et al. 1983. Gasoline sniffing and lead toxicity in Navajo adolescents. Pediatrics 71:113-117.
9. Dawson EB, Evans DR, Harris WA, Teter MC, McGanity WJ. 1999. The effect of ascorbic acid supplementation on the blood lead levels of smokers. J Am Coll Nutr 18:166-170.
10. Deuschl G, Wenzelburger R, Loffler K, Raethjen J, Stolze H. 2000. Essential tremor and cerebellar dysfunction. Clinical and kinematic analysis of intention tremor. Brain 123:1568-1580.
11. Dupuis MJM, Delwaide PJ, Boucquey D, Gonsette RE. 1989. Homolateral disappearance of essential tremor after cerebellar stroke. Mov Disord 4:183-187.
12. Farias P, Hu H, Rubenstein E, Meneses-Gonzalez F, Fishbein E, Palazuelos E, et al. 1998. Determinants of bone and blood lead levels among teenagers living in urban areas with high lead exposure. Environ Health Perspect 106:733-737.
13. Fernandez F, Hilligoss D. 1982. An improved graphite furnace method for the determination of lead in blood using matrix modification and the L'vov platform. Atomic Spectr 3:130-131.
14. Gasparini M, Bonifati V, Fabrizio E, Fabbrini G, Brusa L, Lenzi GL, et al. 2001. Frontal lobe dysfunction in essential tremor. A preliminary study. J Neurol 248:399-402.
15. Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascual-Sedano B. 1999. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol 56:475-480.
16. Gironell A, Kulisevsky J, Lorenzo J, Barbanoj M, Pascual B. 2000. Low frequency repetitive transcranial magnetic stimulation of the cerebellum in patients with essential tremor: a double-blind, cross-over, randomized, placebo-controlled study. Neurology 54(suppl 3):A116-A117.
17. Goldings AS, Stewart RM. 1982. Organic lead encephalopathy: behavioral changes and movement disorder following gasoline inhalation. J Clin Psychiatry 43:70-72.
18. Hernandez-Avila M, Gonzalez-Cossio T, Palzuelos E, Romieu I, Aro W, Fishbein E, et al. 1996. Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect 104:1076-1082.
19. Hornabrook RW, Nagurney JT. 1976. Essential tremor in Papua, New Guinea. Brain 99:659-672.
20. Hu H, Payton M, Korrick S, Aro A, Sparrow D, Weiss ST, et al. 1996. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. Am J Epidemiol 144:749-759.
21. Khatter AS, Kurth MC, Brewer MA, Crinnian CT, Drazkowski JF, Flitman SS, et al. 1996. Prevalence of tremor and Parkinson's disease. Parkinsonism Relat Disord 2:205-208.
22. Konat G, Clausen J. 1974. The effect of long term administration of triethyl lead on the developing rat brain. Environ Physiol Biochem 4:236-242.
23. Kosnett MJ, Becker CE, Osterloh JD, Kelly TJ, Pasta DJ. 1994. Factors influencing blone lead concentration in a suburban community assessed by noninvasive KX-ray fluorescence. JAMA 271:197-203.
24. Lombardi WJ, Woolston DJ, Roberts WJ, Gross RE. 2001. Cognitive deficits in patients with essential tremor. Neurology 57:785-790.
25. Louis ED. 2001. Etiology of essential tremor: should we be searching for environmental causes? Mov Disord 16:822-829.
26. Louis ED, Barnes LF, Albert SM, Cote L, Schneier F, Pullman SL, et al. 2001a. Correlates of functional disability in essential tremor. Mov Disord 16:914-920.
27. Louis ED, Ford B, Bismuth B. 1998a. Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord 13:287-293.
28. Louis ED, Ford B, Frucht S, Barnes LF, Tang M-X, Ottman R. 2001b. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol 49:761-769.
29. Louis ED, Greene P. 2000. Essential tremor. In: Merritt's Textbook of Neurology (Rowland LP, ed), 10th ed. Phildadelphia:Lea & Febiger, 678-679.
30. Louis ED, Jurewicz EC, Watner D. 2003. Community-based data on associations of disease duration and age with severity of essential tremor: implications for disease pathophysiology. Mov Disord 18:90-93.
31. Louis ED, Ottman RA, Ford B, Pullman S, Martinez M, Fahn S, et al. 1997. The Washington Heights Essential Tremor Study: methodologic issues in essential-tremor research. Neuroepidemiology 16:124-133.
32. Louis ED, Ottman R, Hauser WA. 1998b. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord 13:5-10.
33. Louis ED, Pullman S. 2001. Comparison of clinical and electrophysiological methods of diagnosing essential tremor. Mov Disord 16:668-673.
34. Louis ED, Shungu D, Chan S, Mao X, Jurewicz EC, Watner D. 2002a. Metabolic abnormality in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 333:17-20.
35. Louis ED, Zheng W, Jurewicz EC, Watner D, Chen J, Factor-Litvak P, et al. 2002b. Elevation of blood β-carboline alkaloids in essential tremor. Neurology 59:1940-1944.
36. McConnell P, Berry M. 1979. Effects of postnatal lead exposure on Purkinje cell dendritic development in the rat. Neuropathol Appl Biol 5:115-132.
37. Michaelson IA. 1973. Effects of inorganic lead on RNA, DNA and protein content in the developing rat brain. Toxicol Appl Pharmacol 26:539-548.
38. Muldoon SB, Cauley JA, Kuller L, Scott J. 1993. Blood lead levels and neuropsychological function in elderly women. Am J Epidemiol 138:644-645.
39. Payton M, Riggs KM, Spiro A, Weiss ST, Hu H. 1998. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol 20:19-27.
40. Rajput AH, Rozdilsky B, Ang L, Rajput A. 1993. Significance of Parkinsonian manifestations in essential tremor. Can J Neurol Sci 20:114-117.
41. Rautakorpi I, Takala J, Martilla RJ, Sievers K, Rinne UK. 1982. Essential tremor in a Finnish population. Acta Neurol Scand 66:58-67.
42. Sasso E, Perucca E, Fava R, Calzetti S. 1990. Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol 13:67-76.
43. Schroeder HA, Tipton IH. 1968. The human body burden of lead. Arch Environ Health 17:965-978.
44. Seshia SS, Rjani KR, Boeckx RL, Chow PN. 1978. The neurological manifestations of chronic inhalation of leaded gasoline. Dev Med Child Neurol 20:323-334.
45. Singer C, Sanchez-Ramos J, Weiner WJ. 1994. Gait abnormality in essential tremor. Mov Disord 9:193-196.
46. Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. 2000. Gait analysis in essential tremor - further evidence for a cerebellar dysfunction. Mov Disord 15(suppl 3):87.
47. Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, et al. 2001. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 57:1389-1391.
48. Todd AC, Buchanan R, Carroll S, Moshier EL, Popovac D, Slavkovich V, et al. 2001a. Tibia lead levels and methodological uncertainty in 12-year-old children. Environ Res 86:60-65.
49. Todd AC, Chettle DR. 1994. In vivo X-ray fluorescence of lead in bone: review and current issues. Environ Health Perspect 102:172-177.
50. Todd AC, Lee B-K, Lee G-S, Ahn K-D, Moshier EL, Schwartz BS. 2001b. Predictors of DMSA chelatable lead, tibial lead, and blood lead in 802 Korean lead workers. Occup Environ Med 58:73-80.
51. Todd AC, Parsons PJ, Carroll S, Geraghty C, Khan FA, Tang S, et al. 2002. Measurements of lead in human tibiae. A comparison between K-shell X-ray fluorescence and electrothermal atomic absorption spectrometry. Phys Med Biol 47:673-687.
52. Valpey R, Sumi SM, Copass MK, Goble GJ. 1978. Acute and chronic progressive encephalopathy due to gasoline sniffing. Neurology 28:507-510.
53. Walsh TJ, Tilson HA. 1984. Neurobehavioral toxicology of the organoleads. Neurotoxicology 5:67-86.
54. Willett W. 1990. Nutritional Epidemiology. New York:Oxford University Press.
55. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. 1985. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65.
56. Wills AJ, Jenkins IH, Thompson PD, Findley LJ, Brooks DJ. 1994. Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol 36:636-642.
57. Winegar DA, Levy BS, Andrews JS, Landrigan PJ, Scruton WH, Krause MJ. 1997. Chronic occupational exposure to lead: an evaluation of the health of smelter workers. J Occup Med 19:603-606.
58. Young RS, Grzyb SE, Crismon L. 1977. Recurrent cerebellar dysfunction as related to chronic gasoline sniffing in an adolescent girl. Clin Pediatr 16:706-708.